Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein SA pseudogene 60 (RPSAP60) is a processed pseudogene of the ribosomal protein SA gene (RPSA)[1][5][7]. Pseudogenes are non-functional genomic elements that resemble functional genes but do not encode active proteins. RPSAP60 shares sequence similarity with RPSA but contains mutations or sequence alterations that prevent its translation into a functional protein. There is no evidence that RPSAP60 contributes to any biological process or disease phenotype, nor is it a receptor, enzyme, transporter, or other protein target. The biological relevance of RPSAP60 is limited to its use as a genetic marker in certain genomic studies, but it plays no known role in physiology or pathogenesis[5][7].
None known.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein SA pseudogene 60 (RPSAP60).